Lindsay Fischer

Nivolumab plus cabozantinib outperformed sunitinib in maintaining health-related quality of life in patients with advanced renal cell carcinoma.

The FDA set the Under the Prescription Drug User Fee Act date for June 24, 2022.

In this episode of “The Vitals,” Mark Honor, PA-C, discusses adverse event management in patients receiving different therapeutic options.

Experts from Roswell Park developed a dosing guide for the prescription of buprenorphine as treatment for chronic pain.

Mark Honor, PA-C, highlights best adverse event management practices for patients undergoing chemotherapy and immune-based treatment.

Patients who underwent surveillance with bioimpedance spectroscopy were less likely to develop chronic breast cancer–related lymphedema compared with patients who were assessed with tape measure.

Although e-cigarettes are often marketed as a “safe alternative,” non-smokers should understand that smoking still poses risks of lung damage, explains an expert with CTCA.

The program is designed to reduce the age-adjusted death rate associated with cancer by at least 50% over the next 25 years.

Oncology Nursing News® meets with the lead investigator behind the phase 3 IMCgp100-202 trial to better understand the significance of tebentafusp’s approval and to determine what oncology nurses need to know about the new agent.

The oral targeted therapy was linked with maintained appetite, eating habits, and physical function in patients with IDH1-mutated cholangiocarcinoma.

In this episode of “The Vitals,” Dr. Janice Post-White discusses how she balanced working as an oncology nurse through her child’s cancer diagnosis, and the lessons she learned from the experience.

A secondary analysis of the COACH study revealed that a geriatric assessment–guided intervention increased the number of comorbidity-related discussions between patients and providers.

A newly designed model will outline what genetic patterns put men with prostate cancer at an increased risk of toxic side effects.

Tebentafusp is now the first FDA-approved therapy to treat unresectable or metastatic uveal melanoma.

Oncology Home-Hospitalization may represent a feasible alternative to standard ambulatory care and allow patients to spend significantly less time in the outpatient clinic.

New data suggest that patients undergoing immunotherapy achieved better survival outcomes after reporting cutaneous immune-related adverse events.

In a 12-month follow-up, the experimental regimen continued to provide clinical benefit to patients with esophageal cancer without compromising quality of life or exhibiting an unmanageable safety profile.

The presence of Arthrobacter and fatty acid metabolism pathways in gut microbiomes may be linked to an increased risk of skin-related adverse events (AEs) in patients with advanced gastric cancer.

Janelle Wagner, RN, OCN, Senior Manager of Patient Navigation Program for Community Sites, discusses the challenges and rewards of nurse navigation in oncology.

As the HPV vaccine becomes more prevalent, cervical cancer rates are expected to decrease significantly by 2030. However, this trend may differ across socioeconomic communities.

A patient-reported outcome survey highlighted quality-of-life gaps in breast cancer survivorship.

In this episode of “The Vitals,” 2 veteran oncology nurses discuss the value of mentorship—particularly for novice nurses.

Besides education and emotional support, the newly launched program offers personalized services including surgical interventions, hormone replacement therapy, and penile low-intensity shockwave therapy, to help patients heal from their cancer treatments.

Pembrolizumab was associated with the first positive clinical trial outcomes in the adjuvant setting of non–small-cell lung cancer.

New data support increased fiber consumption and decreased probiotic use among patients receiving immunotherapy.

A novel regimen of relatlimab, an LAG-3 inhibitor, plus nivolumab doubled progression-free survival in patients with untreated, advanced melanoma.

New data support smoking cessation for patients with lung cancer following their diagnosis.

Patient advocate Jill Feldman led the development of the language guide to help promote patient-centered, stigma-free language across the lung cancer community.

The 3 subscales of burnout—emotional exhaustion, depersonalization, and a low sense of personal accomplishment—may all contribute to an increase in suicidal ideation among American nurses.

In this episode of “The Vitals,” Nikki Urban, RN, discusses the successful implementation of a phone triage program at Allegheny Health Network.